Pulse Biosciences CS (PLSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,864 | -9,378 | -3,198 | -9,518 | -6,709 |
| Depreciation Amortization | 719 | 396 | 195 | 763 | 572 |
| Accounts payable and accrued liabilities | 649 | 586 | 517 | 3 | 184 |
| Other Working Capital | 499 | 2,222 | 241 | -166 | -223 |
| Other Operating Activity | 7,873 | 2,467 | -254 | 867 | 443 |
| Operating Cash Flow | $-7,124 | $-3,707 | $-2,499 | $-8,051 | $-5,733 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,407 | -2,464 | N/A | -64 | -64 |
| Purchase Of Investment | -11,363 | -11,363 | -7,610 | -19,067 | -14,096 |
| Sale Of Investment | 16,034 | 12,249 | 5,800 | 4,750 | N/A |
| Investing Cash Flow | $2,264 | $-1,578 | $-1,810 | $-14,381 | $-14,160 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 35,194 | 5,186 | 4,971 | 20,915 | 20,915 |
| Financing Cash Flow | $35,194 | $5,186 | $4,971 | $20,915 | $20,915 |
| Beginning Cash Position | 2,089 | 2,089 | 2,089 | 3,606 | 3,606 |
| End Cash Position | 32,423 | 1,990 | 2,751 | 2,089 | 4,628 |
| Net Cash Flow | $30,334 | $-99 | $662 | $-1,517 | $1,022 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,124 | -3,707 | -2,499 | -8,051 | -5,733 |
| Capital Expenditure | -2,407 | -2,464 | N/A | -64 | -64 |
| Free Cash Flow | -9,531 | -6,171 | -2,499 | -8,115 | -5,797 |